×

News

-

Chemotherapy With FOLFOX Superior to TACE in Liver Cancer

Nov 12, 2021

Post image

Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a randomized, phase 3 trial has shown.

In a group of 315 patients with unresectable tumors at least 7 cm in diameter and no macrovascular invasion or extrahepatic spread, overall survival (OS) was 42% longer at 23. 1 months for patients treated with FOLFOX-HAIC, compared with 16

Success

You just clicked the toast button, this toast will be closed in 2s..

×